Luis Escobar-López
Luis Escobar-López publishes mostly in Cardiology and Cardiovascular Medicine, Molecular Biology and Rheumatology, on topics such as Cardiomyopathy and Myosin Studies, Cardiac electrophysiology and arrhythmias and Viral Infections and Immunology Research.
- World rank
- #1,213,928 of 7,710,434 ranked researchers
- Rank in Spain
- #24,691 of 204,306
- Works
- 15
- Citations
- 778
- Citations per work
- 51.9
What does Luis Escobar-López research?
Luis Escobar-López's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1173.3%
- Medicine1173.3%
- Life Sciences215.5%
- Everything else211.2%
- 1Cardiology and Cardiovascular Medicine58% of their works
- 2Molecular Biology13% of their works
- 3Rheumatology7% of their works
- 4Hematology4% of their works
- 5Physiology4% of their works
- 6Immunology2% of their works
Research topics
- Cardiomyopathy and Myosin Studies
- Cardiac electrophysiology and arrhythmias
- Viral Infections and Immunology Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Congenital heart defects research
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Pericarditis and Cardiac Tamponade
Which keywords describe Luis Escobar-López's research?
The keywords of their largest research topics: Cardiomyopathies, Genetic Mutations, Heart Failure, Cardiovascular Magnetic Resonance, Epidemiology, Arrhythmias, Diagnosis and Echocardiography.
- Transthyretin
- Heart Regeneration
- Diastolic Function
- Chamber Quantification
- Cardiac Amyloidosis
- Viral Infection
- Myocarditis
- Echocardiography
- Arrhythmias
- Cardiovascular Magnetic Resonance
- Genetic Mutations
- Cardiomyopathies
- Heart Failure
- Epidemiology
- Diagnosis
- Long-QT Syndrome
- Treatment
- B-Type Natriuretic Peptide
- Cardiomyocyte Renewal
- Constrictive Pericarditis
- Guidelines
- Pericarditis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Cardiomyopathies81 topic
- Genetic Mutations81 topic
- Heart Failure83 topics
- Cardiovascular Magnetic Resonance62 topics
- Epidemiology62 topics
- Arrhythmias41 topic
- Diagnosis42 topics
- Echocardiography42 topics
- Long-QT Syndrome41 topic
- Myocarditis41 topic
- Treatment42 topics
- Viral Infection41 topic
- B-Type Natriuretic Peptide21 topic
- Cardiac Amyloidosis21 topic
- Cardiomyocyte Renewal21 topic
- Chamber Quantification21 topic
- Constrictive Pericarditis21 topic
- Diastolic Function21 topic
- Guidelines21 topic
- Heart Regeneration21 topic
- Pericarditis21 topic
- Transthyretin21 topic
Where does Luis Escobar-López work?
Luis Escobar-López's main affiliation in the publication record is Universidad Francisco de Vitoria, Spain.
How many publications and citations does Luis Escobar-López have?
OpenAlex counts 15 works and 778 citations for Luis Escobar-López, an h-index of 11, ranking #1,213,928 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luis Escobar-López. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.